tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB

Compare Biogen (BIIB) vs. Competitors

Compare
4,989 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Biogen
$179.89
$26.39B
16.41
23.02%
9 Buy
12 Hold
1 Sell
Moderate Buy
Amgen
$341.88
$184.10B
26.51
20.37%
11 Buy
8 Hold
1 Sell
Moderate Buy
Bristol-Myers Squibb
$55.05
$112.07B
18.33
-6.92%
8 Buy
11 Hold
1 Sell
Moderate Buy
Gilead Sciences
$141.95
$176.11B
21.61
46.42%
14 Buy
3 Hold
0 Sell
Strong Buy
GlaxoSmithKline
$51.60
$103.65B
14.25
45.93%
1 Buy
3 Hold
2 Sell
Hold
AbbVie
$223.01
$394.14B
166.32
26.96%
10 Buy
7 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BIIB
Biogen
179.89
37.55
26.38%
AMGN
Amgen
341.88
62.12
22.20%
BMY
Bristol-Myers Squibb
55.05
-2.02
-3.54%
GILD
Gilead Sciences
141.95
46.25
48.33%
GSK
GlaxoSmithKline
51.60
18.13
54.15%
ABBV
AbbVie
223.01
39.04
21.22%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts